Roper said revenue from continuing operations for Q4 2023 rose 13% to $1.61 billion, and full-year revenue rose 15% to $6.18 billion. The company said organic revenue for the year grew 8%.

1. 01

   Roper said revenue from continuing operations for Q4 2023 rose 13% to $1.61 billion, and full-year revenue rose 15% to $6.18 billion. The company said organic revenue for the year grew 8%.

2. 02

   The company said full-year 2023 GAAP DEPS from continuing operations rose 38% to $12.74, and adjusted DEPS rose 17% to $16.71. It said full-year adjusted EBITDA increased 16% to $2.51 billion.

3. 03

   Roper said full-year 2023 GAAP operating cash flow from continuing operations was $2.04 billion, and adjusted operating cash flow rose 33% to $2.07 billion. It said full-year adjusted free cash flow was $1,962 (in millions).

4. 04

   The company said it expects full-year 2024 adjusted DEPS of $17.85 to $18.15, and Q1 adjusted DEPS of $4.30 to $4.34. It expects full-year total revenue growth of +11 to 12% and organic revenue growth of +5 to 6%, and said its guidance includes the impact of the Procare Solutions acquisition.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.